Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $33.5 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.